{"entity":{"id":"nct06609005","kind":"trial","name":"A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer","aka":[],"tldr":"A phase 1/2 trial of INV-9956 in prostate cancer, run by Shenzhen Ionova Life Sciences Co., Ltd., now recruiting.","summary":"A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer is a phase 1/2 interventional study registered as NCT06609005 by Shenzhen Ionova Life Sciences Co., Ltd., with 84 participants planned, started 2025-01-23 and due to reach its primary completion in 2028-01-17. Interventions recorded: INV-9956.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT06609005","url":"https://clinicaltrials.gov/study/NCT06609005"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["prostate"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["shenzhen-ionova-life-sciences"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT06609005","phase":"1/2","setting":"A Phase 1 and Phase 2, Multi-Center, Open-Label Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Evidence of Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer","sponsor":"Shenzhen Ionova Life Sciences Co., Ltd.","enrolled":84,"outcomes":[]},"route":"/trials/nct06609005/","neighbours":{"cancer":[{"id":"prostate","kind":"cancer","name":"Prostate cancer","route":"/cancers/prostate/"}],"company":[{"id":"shenzhen-ionova-life-sciences","kind":"company","name":"Shenzhen Ionova Life Sciences","route":"/companies/shenzhen-ionova-life-sciences/"}]}}